Correlation Between Pfizer and Astoria Quality
Can any of the company-specific risk be diversified away by investing in both Pfizer and Astoria Quality at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Astoria Quality into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Astoria Quality Kings, you can compare the effects of market volatilities on Pfizer and Astoria Quality and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Astoria Quality. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Astoria Quality.
Diversification Opportunities for Pfizer and Astoria Quality
0.1 | Correlation Coefficient |
Average diversification
The 3 months correlation between Pfizer and Astoria is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Astoria Quality Kings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astoria Quality Kings and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Astoria Quality. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astoria Quality Kings has no effect on the direction of Pfizer i.e., Pfizer and Astoria Quality go up and down completely randomly.
Pair Corralation between Pfizer and Astoria Quality
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Astoria Quality. In addition to that, Pfizer is 1.21 times more volatile than Astoria Quality Kings. It trades about -0.05 of its total potential returns per unit of risk. Astoria Quality Kings is currently generating about -0.04 per unit of volatility. If you would invest 3,045 in Astoria Quality Kings on December 28, 2024 and sell it today you would lose (80.00) from holding Astoria Quality Kings or give up 2.63% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. Astoria Quality Kings
Performance |
Timeline |
Pfizer Inc |
Astoria Quality Kings |
Pfizer and Astoria Quality Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Astoria Quality
The main advantage of trading using opposite Pfizer and Astoria Quality positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Astoria Quality can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astoria Quality will offset losses from the drop in Astoria Quality's long position.Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
Astoria Quality vs. JPMorgan Fundamental Data | Astoria Quality vs. Vanguard Mid Cap Index | Astoria Quality vs. SPDR SP 400 | Astoria Quality vs. SPDR SP 400 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |